Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers
- PMID: 27660108
- PMCID: PMC5034448
- DOI: 10.1186/s12968-016-0281-y
Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers
Abstract
Background: Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that occurs in males leading to immobility and death in early adulthood. Female carriers of DMD are generally asymptomatic, yet frequently develop dilated cardiomyopathy. This study aims to detect early cardiac manifestation in DMD using cardiovascular magnetic resonance (CMR) and to evaluate its association with clinical symptoms.
Methods: Clinical assessment of DMD carriers included six minutes walk tests (6MWT), blood analysis, electrocardiography, echocardiography, and CMR using FLASH sequences to detect late gadolinium enhancement (LGE). T1-mapping using the Modified Look-Locker Inversion recovery (MOLLI) sequence was performed quantify extracellular volume (ECV).
Results: Of 20 carriers (age 39.47 ± 12.96 years) 17 (89.5 %) were clinically asymptomatic. ECV was mildly elevated (29.79 ± 2.92 %) and LGE was detected in nine cases (45 %). LGE positive carriers had lower left ventricular ejection fraction in CMR (64.36 ± 5.78 vs. 56.67 ± 6.89 %, p = 0.014), higher bothCK (629.89 ± 317.48 vs. 256.18 ± 109.10 U/l, p = 0.002) and CK-MB (22.13 ± 5.25 vs. 12.11 ± 2.21 U/l, p = 0.001), as well as shorter walking distances during the 6MWT (432.44 ± 96.72 vs. 514.91 ± 66.80 m, p = 0.037). 90.9 % of subjects without LGE had normal pro-BNP, whereas in 66.7 % of those presenting LGE pro-BNP was elevated (p = 0.027). All individuals without LGE were in the NYHA class I, whereas all those in NYHA classes II and III showed positive for LGE (p = 0.066).
Conclusions: Myocardial involvement shown as LGE in CMR occurs in a substantial number of DMD carriers; it is associated with clinical and morphometric signs of incipient heart failure. LGE is thus a sensitive parameter for the early diagnosis of cardiomyopathy in DMD carriers.
Trial registration: Clinicaltrials.gov, NCT01712152 Trial registration: October 19, 2012. First patient enrolled: September 27, 2012 (retrospectively registered).
Keywords: Cardiomyopathy; Cardiovascular magnetic resonance; Duchenne muscular dystrophy; T1-mapping.
Figures
Similar articles
-
T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T.J Cardiovasc Magn Reson. 2020 Dec 10;22(1):85. doi: 10.1186/s12968-020-00687-z. J Cardiovasc Magn Reson. 2020. PMID: 33302967 Free PMC article.
-
Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.J Cardiovasc Magn Reson. 2016 Oct 28;18(1):72. doi: 10.1186/s12968-016-0292-8. J Cardiovasc Magn Reson. 2016. PMID: 27788681 Free PMC article.
-
Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.J Cardiovasc Magn Reson. 2016 Jan 21;18:5. doi: 10.1186/s12968-016-0224-7. J Cardiovasc Magn Reson. 2016. PMID: 26795569 Free PMC article.
-
Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12842. Epub 2017 Oct 26. Eur J Clin Invest. 2017. PMID: 28981141 Review.
-
Oedema-fibrosis in Duchenne Muscular Dystrophy: Role of cardiovascular magnetic resonance imaging.Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12843. Epub 2017 Oct 31. Eur J Clin Invest. 2017. PMID: 29027210 Review.
Cited by
-
Prenatal diagnosis for a Chinese family with a de novo DMD gene mutation: A case report.Medicine (Baltimore). 2017 Dec;96(50):e8814. doi: 10.1097/MD.0000000000008814. Medicine (Baltimore). 2017. PMID: 29390271 Free PMC article.
-
Journal of Cardiovascular Magnetic Resonance 2017.J Cardiovasc Magn Reson. 2018 Dec 28;20(1):89. doi: 10.1186/s12968-018-0518-z. J Cardiovasc Magn Reson. 2018. PMID: 30593280 Free PMC article. Review.
-
Duchenne Dilated Cardiomyopathy: Cardiac Management from Prevention to Advanced Cardiovascular Therapies.J Clin Med. 2020 Oct 1;9(10):3186. doi: 10.3390/jcm9103186. J Clin Med. 2020. PMID: 33019553 Free PMC article. Review.
-
Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach.Front Physiol. 2018 Dec 21;9:1770. doi: 10.3389/fphys.2018.01770. eCollection 2018. Front Physiol. 2018. PMID: 30622476 Free PMC article.
-
SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.J Cardiovasc Magn Reson. 2022 Jul 21;24(1):44. doi: 10.1186/s12968-022-00873-1. J Cardiovasc Magn Reson. 2022. PMID: 35864534 Free PMC article. Review.
References
-
- Bushby KM. The muscular dystrophies. Baillieres Clin Neurol. 1994;3:407–430. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous